Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an...
Read more
Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and...
Read more
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from...
Read more
CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced...
Read more
Jazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a...
Read moreNeuraltus Pharmaceuticals announced the confirmatory Phase 2 study of the Company’s lead investigational treatment NP001 for amyotrophic lateral sclerosis (ALS,...
Read more
The agreement will benefit clinical trials, delivering Suvoda’s cutting edge IRT/IWRS technology for subject randomization and trial supply management integrated...
Read moreImmunoCellular Therapeutics, Ltd announced the presentation of updated immune monitoring data from the phase 2 trial of ICT-107 in patients...
Read moreEli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the...
Read moreAstraZeneca announced that the Phase III AURA3 trial met its primary endpoint, demonstrating superior progression-free survival (PFS) compared to standard...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
